Table 8.
Frequency of RL values and basic ChSI phenomena in groups of patients with chronic nosologies.
| Group | RL, % | SIR, % |
Systemic Alteration % | Microthrombosis, % | Distress of HPA, % | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | |||||
| Control 1 (donors), n = 50 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Control 2 (elderly people), n = 22 | 81.8 | 18.2 | 0 | 0 | 0 | 0 | 18.2 | 0 | 0 | 0 |
| SLE, n = 49 | 8.2 | 4.1 | 16.3 | 32.6 | 34.7 | 4.1 | 91.8 | 6.1 | 40.8 | 28.6 |
| RA, n = 42 | 31.0 | 47.6 | 19.0 | 2.4 | 0 | 0 | 69.0 | 7.1 | 54.8 | 28.6 |
| ReA, n = 30 | 46.7 | 33.3 | 20.0 | 0 | 0 | 0 | 53.3 | 0 | 23.3 | 43.3 |
| AS, n = 27 | 44.5 | 33.3 | 22.2 | 0 | 0 | 0 | 55.5 | 3.7 | 11.1 | 7.4 |
| PsA, n = 12 | 33.3 | 50.0 | 16.7 | 0 | 0 | 0 | 66.7 | 8.3 | 8.3 | 8.3 |
| RHD, n = 15 | 53.5 | 33.3 | 13.2 | 0 | 0 | 0 | 46.7 | 0 | 13.3 | 14.3 |
| CHF, n = 49 | 53.1 | 36.7 | 10.2 | 0 | 0 | 0 | 46.9 | 2.0 | 33.3 | 2.0 |
| ESRD, n = 42 | 4.8 | 16.6 | 54.8 | 21.4 | 2.4 | 0 | 95.2 | 92.9 | 38.1 | 14.3 |
| CLI, n = 38 | 5.3 | 31.6 | 52.6 | 10.5 | 0 | 0 | 94.7 | 50.0 | 47.4 | 34.2 |
| CNW, n = 42 | 19.0 | 78.6 | 2.4 | 0 | 0 | 0 | 81.0 | 2.4 | 9.5 | 45.2 |
| AIT, n = 29 | 79.3 | 20.7 | 0 | 0 | 0 | 0 | 20.7 | 0 | 0 | 3.4 |
| PID, n = 16 | 75.0 | 25.0 | 0 | 0 | 0 | 0 | 25.0 | - * | 0 | - * |
| Menopausal syndrome, n = 16 | 93.7 | 6.3 | 0 | 0 | 0 | 0 | 6.3 | 0 | 0 | 0 |
| CRAD, n = 23 | 8.7 | 69.6 | 17.4 | 4.3 | 0 | 0 | 91.3 | 30.4 | 21.7 | 56.5 |
| Normal function of renal allograft, n = 24 | 58.3 | 25.0 | 16.7 | 0 | 0 | 0 | 41.7 | 0 | 4.2 | 29.2 |
| PAPS, n = 5 | 0 | 0 | 20.0 | 80.0 | 0 | 0 | 100 | - * | 100 | - * |
Note. RL—reactivity level; SI—systemic inflammation; ChSI—chronic systemic inflammation; SLE—systemic lupus erythematosus; RA—rheumatoid arthritis; ReA—reactive arthritis; AS—ankylosing spondylitis; PsA—psoriatic arthritis; RHD—chronic rheumatic valvular heart disease; CHF—chronic heart failure; ESRD—end-stage renal disease; CLI—chronic limb threatening ischemia; CNW—chronic nonhealing wounds; AIT—autoimmune thyroiditis; PID—pelvic inflammatory disease; CRAD—chronic renal allograft dysfunction; PAPS-primary antiphospholipid syndrome. *—markers of the phenomenon were not measured in this group.